⚠ LIVE — European Consumer Safety Watch 💊 Medicines: 17 in last 7 days 🍎 Food: 0 in last 7 days 🧸 Products: 113 in last 7 days 🟢 Monitoring: EMA · RASFF · NVWA · FAGG · FAVV · EFSA · Safety Gate ⏱ Last fetch: 10 minutes ago ⚠ LIVE — European Consumer Safety Watch 💊 Medicines: 17 in last 7 days 🍎 Food: 0 in last 7 days 🧸 Products: 113 in last 7 days 🟢 Monitoring: EMA · RASFF · NVWA · FAGG · FAVV · EFSA · Safety Gate ⏱ Last fetch: 10 minutes ago

🛡️ EU Safety Watch EUSW

🇬🇧 en

🇬🇧 English 🇳🇱 Nederlands 🇫🇷 Français 🇩🇪 Deutsch 🇪🇸 Español 🇮🇹 Italiano 🇵🇹 Português 🇵🇱 Polski 🇸🇪 Svenska 🇷🇴 Română 🇨🇿 Čeština 🇫🇮 Suomi 🇩🇰 Dansk

🇩🇪 Germany

Recent safety notifications affecting this country.

💊 Medicines

0

last 30 days

🍎 Food

146

last 30 days

🧸 Products

57

last 30 days

Medium EU resolved 12 years ago

Increlex

INN: mecasermin · Forms: Solution for subcutaneous injection · Strengths: 10 mg/ml · Area: Laron Syndrome · Alternatives: No

Medium EU resolved 12 years ago

Increlex

INN: mecasermin · Forms: Solution for subcutaneous injection · Strengths: 10 mg/ml · Area: Laron Syndrome · Alternatives: No

Medium EU resolved 12 years ago

Cerezyme

INN: imiglucerase · Forms: Solution for infusion · Area: Gaucher Disease · Alternatives: No

Medium EU resolved 12 years ago

Fabrazyme

INN: agalsidase beta · Forms: Powder for concentrate for solution for infusion · Strengths: 5 mg;35 mg · Area: Fabry Disease · Alternatives: No

Medium EU resolved 12 years ago

Cerezyme

INN: imiglucerase · Forms: Solution for infusion · Area: Gaucher Disease · Alternatives: No

Medium EU resolved 12 years ago

Fabrazyme

INN: agalsidase beta · Forms: Powder for concentrate for solution for infusion · Strengths: 5 mg;35 mg · Area: Fabry Disease · Alternatives: No

⚠️ We aggregate official notices. We do not give medical advice. For medical or legal decisions, consult the source agency and a qualified professional.